Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Seborrheic Dermatitis: early-phase trial registry
1 of 3 indexed Seborrheic Dermatitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Seborrheic Dermatitis: 3 US clinical trials tracked, 1 recruiting.
Seborrheic Dermatitis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Arcutis Biotherapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition seborrheic-dermatitis
OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Seborrheic Dermatitis lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Seborrheic Dermatitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Seborrheic Dermatitis is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
Integrative Skin Science and Research
NCT05942248
Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Arcutis Biotherapeutics
NCT04091646
Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
University of California, Davis
NCT03114111
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Seborrheic Dermatitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Seborrheic Dermatitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Seborrheic Dermatitis page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Seborrheic Dermatitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Arcutis Biotherapeutics sponsors the most Seborrheic Dermatitis trials on record, review their full trial history before evaluating a specific study. See Arcutis Biotherapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Seborrheic Dermatitis condition card totals 3 registered trials; most-linked intervention Vehicle foam; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.